The use of novel biochemical markers in predicting spontaneously resolving 'pregnancies of unknown location'

Human Reproduction

Volumn 26, Issue 6, 2011, Pages 1318-1323

  Chetty, M ^a   Sawyer, E ^b   Dew, T ^c   Chapman, A J ^d   Elson, J ^e  

^a BORDERS GENERAL HOSPITAL   (United Kingdom)

^b Church Walk Surgery   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

ectopic pregnancy; inhibin pro C related immunoreactivity; insulin like growth factor binding protein 1; pregnancy of unknown location; progesterone

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; INHIBIN A; INHIBIN PRO ALPHA C RELATED IMMUNOREACTIVITY; PROGESTERONE; SOMATOMEDIN BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DISEASE MARKER; ECTOPIC PREGNANCY; FEMALE; FETAL WELL BEING; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PREGNANCY; PREGNANCY DISORDER; PREGNANCY OF UNKNOWN LOCATION; PROGESTERONE BLOOD LEVEL;

EID: 79957523508     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der064     Document Type: Article

References (21)

1. Ankum WM, Van derVeen F, Hamerlynck JVTH, Lammes FB. Transvaginal sonography and human chorionic gonadotrophin measurements in suspected ectopic pregnancy: A detailed analysis of a diagnostic approach. Hum Reprod 1993;8:1307-1311. (Pubitemid 23249542)
2. Banerjee S, Aslam N, Zosmer N, Woelfer B, Jurkovic D. The expectant management of women with pregnancies of unknown location. Ultrasound Obstet Gynecol 1999;14:231-236.
3. Banerjee S, Aslam N, Woelfer B, Lawrence A, Elson J, Jurkovic D. Expectant management of early pregnancies of unknown location: A prospective evaluation of methods to predict spontaneous resolution of pregnancy. BJOG 2001;108:158-163. (Pubitemid 32164926)
4. Ben Lagha N, Seurin D, Le Bouc Y, Binoux M, Berdal A, Menuelle P, Babajko S. Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: Study on IGFBP-1 overexpressing transgenic mice. Endocrinol 2006;147:4730-4737. (Pubitemid 44402181)
5. Birdsall M, LedgerW, Groome N, Abdalla H, Muttukrishna S. Inhibin a and activin a in the first trimester of human pregnancy. J Clin Endocrinol Metab 1997;82:1557-1560. (Pubitemid 27200434)
6. Condous G, Okaro E, Khalid A, Timmerman D, Lu C, Zhou Y, Van Huffel S, Bourne T. The use of a new logistic regression model for predicting the outcome of pregnancies of unknown location. Hum Reprod 2004;19:1900-1910. (Pubitemid 39144642)
7. Day A, Sawyer E, Mavrelos D, Tailor A, Jurkovic D. Use of serum progesterone measurements to reduce need for follow up in women with pregnancies of unknown location. Ultrasound Obstet Gynecol 2009;33:704-710.
8. Elson J, Tailor A, Salim R, Hillaby K, Dew T, Jurkovic D. Expectant management of miscarriage-prediction of outcome using ultrasound and novel biochemical markers. Hum Reprod 2005; 20:2330-2333. (Pubitemid 41418527)
9. Facey CL, Chetty M, Edmondson J, Elson J. Does a PUL protocol work in a DGH? Ultrasound Obstet Gynecol 2006;28:377.
10. Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG. A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-AB, pro-aC and follistatin during pregnancy. Hum Reprod 1998;13:3530-3536. (Pubitemid 29002653)
11. Hahlin M, Thorburn J, Bryman I. The expectant management of early pregnancies of uncertain site. Hum Reprod 1995;10:1223-1227.
12. Ilingworth PJ, Groome NP, Duncan WC, Grant V, Tovanabutra S, Baird DT, McNeilly AS. Measurement of circulating inhibin forms during the establishment of pregnancy. J Clin Endocrinol Metab 1996; 81:1471-1475. (Pubitemid 26119667)
13. Irwin JC, Giudice LC. Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast a5b1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res 1998;8:21-31. (Pubitemid 29132915)
14. Kirk E, Papageorghiou AT, Van Calster B, Condous G, Cowans N, Van Huffel S, Timmerman D, Spencer K, Bourne T. The use of serum inhibin a and activin a levels in predicting the outcome of 'pregnancies of unknown location'. Hum Reprod 2009;24:2451-2456.
15. Kurtz AB, Shlansky-Goldberg RD, Choi HY. Detection of retained products of conception following spontaneous abortion in the first trimester. J Ultrasound Med 1991;6:126-129.
16. Lahiri S, Anobile CJ, Stewart P, Ledger W. Changes in circulating concentrations of inhibins A and pro a-C during first trimester medical termination of pregnancy. Hum Reprod 2003;18:744-748. (Pubitemid 36426951)
17. Lockwood GM, Ledger WL, Barlow DH, Groome NP, Muttukrishna S. Measurement of inhibin and activin in early human pregnancy: Demonstration of fetoplacental origin and role in prediction of early-pregnancy outcome. Biol Reprod 1997;57:1490-1494. (Pubitemid 27516657)
18. Matsumoto H, Sakai K, Iwashita M. Insulin-like growth factor binding protein-1 induces decidualization of human endometrial stromal cells via alpha 5 beta1 integrin. Mol Hum Reprod 2008;14:485-489.
19. Muttukrishna S, Fowler PA, Groome NP, Mitchell CG, Robertson WR, Knight PG. Serum concentrations of dimeric inhibin during spontaneous menstrual cycle and after treatment with endogenous gonadotrophin. Hum Reprod 1994;9:1634-1642. (Pubitemid 24291075)
20. Muttukrishna S, Child TJ, Groome NP, Ledger WL. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod 1997;12:1089-1093. (Pubitemid 27271776)
21. Rulin MC, Bornstein SG, Campbell JD. The reliability of ultrasonography in the management of spontaneous abortion, clinically thought to be complete: A prospective study. Am J Obstet Gynecol 1993;168:12-15. (Pubitemid 23047604)